Skopos Labs, Inc. Royalty Pharma PLC Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,158 shares of RPRX stock, worth $38,515. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,158
Previous 963
20.25%
Holding current value
$38,515
Previous $24,000
50.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.36 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$766 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$446 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$405 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.5B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...